48 results
Page 2 of 3
8-K
EX-10.1
18e6 uux1e5
24 Mar 21
NeuroBo Pharmaceuticals Receives Approval for Amendment of Contingent Value Rights for Gemcabene
8:15am
8-K
EX-2.1
8sus8or51
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
424B5
4q8dmghlcz
15 Apr 20
Prospectus supplement for primary offering
5:19pm
8-K
EX-4.1
zasbd6
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
8-K
toqqcxjfy4ki42v
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
8-K
EX-10.1
zzi637pfwtziah0
13 Feb 20
Departure of Directors or Certain Officers
4:01pm
8-K/A
ao5p0sjii fj
7 Jan 20
Changes in Registrant's Certifying Accountant
10:27am
8-K
EX-10.3
ylzm4
30 Dec 19
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
9:04pm
8-K
EX-10.1
xezdemi
30 Dec 19
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
9:04pm
424B3
gbyxl70yuexp8
6 Nov 19
Prospectus supplement
9:15am
425
EX-3.1
mu9 elnzmfk1c
30 Oct 19
Business combination disclosure
12:00am
8-K
EX-3.1
poe uxma3m
30 Oct 19
Entry into a Material Definitive Agreement
12:00am
S-4/A
623jvi9 2p5pyxi
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4
EX-10.37
e8xd3ljup 2ihaw
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.39
f6vnv76dwgyom4o xxa8
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.40
63yrxo 8534nc5jw3n
3 Sep 19
Registration of securities issued in business combination transactions
12:00am